CRT-D device reduces hospital admissions for mild cardiac symptoms

09/1/2009 | Boston Globe (tiered subscription model), The

A combination of defibrillator and a cardiac-resynchronization therapy device proved effective in reducing the chances of patients being hospitalized for less severe forms of cardiac failure, according to a study sponsored by Boston Scientific. By the end of the year, Boston Scientific will ask the FDA to grant "indication expansion" for the CRT-D device, which was already approved for use in those with advanced forms of congestive heart failure, said Fred Colen, president of the company's cardiac rhythm management unit.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ